LifeTec Group - Quarterly Report: Q2 2018
second quarter of 2018

Summer has arrived and the second quarter of the year has already come and gone.

From a sun-drenched Netherlands, where it’s 27 degrees Celsius at the moment (80 to 84 Fahrenheit), now is a good time to look back on this second quarter of 2018: 

LifeTec Group - Quarterly Report; Q2 2018
Globetrotters

LifeTec Group was in Mannheim, Chicago, Maastricht, Barcelona, Washington and many other places all over the world.

When we’re on location, it’s often with one of our Cardiac Biosimulator platforms, to introduce surgeons to the application of a medical device in a ‘hands on’ kind of way. Although we facilitate such training sessions several times a week, it’s never a ‘routine job’. 

Sjoerd (van Tuijl) and Jurgen (de Hart) talk briefly about their trip to TVT Chicago >> read more >>

LifeTec Group - Vascular Bioreactor Platform
“… on a chip” or “… in a box”?

“Organ on a chip”, “Heart on a chip”, “Asthma on a Chip”, “Lab on a chip”. You probably haven’t failed to notice the many “on a chip” developments.

LifeTec Group is involved in quite a few of them, and the reason is not so much because we’re into electronic chips, but because our colleagues are really good at the “bio in a box” concept:

 

<< Photo: Vascular Bioreactor Platform ("Blood vessels 'in a box'")

"Bio-in-a-Box"

It’s about real-life organs like hearts and livers, real-life veins, and bone / cartilage biopsies “in a box”. They are kept ‘alive’ and in working order for hours, days, and sometimes even weeks by the researchers and engineers at LifeTec Group. This opens up a wide range of possibilities for their fellow researchers and for developers of medical devices and therapies: 

 

Coronary stent in a box 

Erasmus Medical Center, Delft University of Technology and LifeTec Group work together to develop vascular models and cell culture models, free of animal testing, in order to imitate healthy and diseased human blood vessel walls >> read more >>

 

Blood vessels in a box

"Towards the development of a pathological ex vivo blood vessel model: a possible alternative to ‘petri dishes’ as well as to animal testing" (Scientific Paper) >> read more >>

La Famiglia

Growing fast is a good thing for a company. However, at LifeTec Group we are very much aware that it’s the people who make the company, and it’s the people who turn it into something special.

So, fast growth should be a good thing not only for the company itself, but also for the people who make it into what it is.

2018 is only six months old and we’ve already added six new ‘family members’ to the LifeTec Group ‘famiglia’:

Anke Waterschoot, Martina Puricelli, Tim van den Boom and Bettine van Willigen will introduce themselves to you soon.

Bart Smeets, Mattia D’Alessi and Naudia Singh introduced themselves recently on the LifeTec Group website:

 

LifeTec Group - Quarterly Report: Q2 2018
Promising Rookies

In the past quarter, our ‘promising rookies’ Benjamin Kappler and Noemi Vanerio travelled to Washington to present their projects and the progress they made, to an audience of hundreds of medical professionals from all over the world. 

Soon after this trip to Washington, Benjamin received some good news: a scientific paper he submitted has been accepted. 

Head of MedTech Innovation

Marco Stijnen

R&D Engineer

Luca Paroni

Head of Research

Linda Kock

Medical Director

Bas de Mol

R&D Engineer

Marcel Wijlaars

R&D Engineer

Benjamin Kappler

Senior Research Engineer

Sjoerd van Tuijl

Biochemical Engineer

Melanie Krüger

R&D Engineer

Noemi Vanerio

Marketing & Communications

Toine Nagel

CEO

Jurgen de Hart

Office Manager

Janneke Cuijpers

R&D technician

Elke van Soest

R&D engineer

Dave Wanders

R&D Engineer

Bart Smeets

R&D Engineer

Mattia D'Alessi

Financial Administrator

Naudia Singh

Project Manager and Engineer

Anke Waterschoot

R&D Engineer

Martina Puricelli

Junior R&D Engineer

Tim van den Boom

Junior R&D Engineer

Bettine van Willigen

©2018 LifeTec Group.  Legal  Credits